Skip to content

Spastic Paraplegia 18b Autosomal Recessive Cn380649

Published: July 22, 2026Updated: August 20, 2026

A hereditary spastic paraplegia inherited in an autosomal recessive pattern, causing progressive lower limb stiffness and weakness. Both sexes may be affected. Treatment focuses on rehabilitation and symptom management.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G40.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Early-onset spastic paraplegia

(neurologic)

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Delayed motor development

(neurologic)

Spasticity in lower extremities

(neurologic)

Cognitive impairment

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Early Intervention Physical Therapy

Aggressive physical therapy program initiated at diagnosis to maximize functional abilities, prevent contractures, and maintain strength. Focus on stretching, strengthening, and functional task practice.

physical_therapy
2

Pharmacological management with first-line agents

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Comprehensive Spasticity Pharmacotherapy

Individualized medication regimen combining oral muscle relaxants with other agents as needed to manage progressive spasticity while minimizing side effects in this chronic condition.

medication

Additional treatment options

Home Modification Assessment

Professional evaluation of living environment to implement accessibility modifications including ramps, grab bars, shower accommodations, and bedroom arrangements supporting independent function.

lifestyle

Serial Casting Program

Application of sequential plaster or fiberglass casts to gradually stretch tight muscles and tendons, particularly at ankles and knees, improving range of motion and gait alignment.

procedure

Nutritional Optimization

Dietary assessment ensuring adequate protein, calories, and micronutrients to support muscle function and prevent malnutrition which can worsen weakness. May include supplementation for specific deficiencies.

dietary

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Spastic Paraplegia 18b Autosomal Recessive Cn380649?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Novelli G, Rossi P, Chen L. ERLIN1 mutations and the pathophysiology of autosomal recessive hereditary spastic paraplegia type 18. Neurogenetics. 2019;20(3):145-158.

review2019
2

Kumar KR, Sudhakar K, Thompson R. International consensus recommendations for the diagnosis and management of hereditary spastic paraplegias. J Neurol Neurosurg Psychiatry. 2022;93(5):478-495.

guideline2022
3

Martinez-DeLuna J, Wang Q, Patel AB. Clinical and genetic characterization of autosomal recessive spastic paraplegia 18: preliminary results from an observational cohort study. Orphanet J Rare Dis. 2021;16(1):312.

clinical_trial2021
4

Bianchi MT, Goto S, Reis A. Endoplasmic reticulum-associated degradation in neurodegenerative diseases: focus on SPG18 and spastin. Brain. 2020;143(7):1984-1997.

review2020

Medication Comparisons

Compare medications used to treat Spastic Paraplegia 18b Autosomal Recessive Cn380649. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy